UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

OPKO Health, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

Not Applicable
______________________________________________
Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

On January 22, 2017, Robert A. Baron notified OPKO Health, Inc., a Delaware corporation (the “Company”) that he was retiring from service on the Company’s board of directors (the “Board”), effective January 23, 2017. Mr. Baron previously served as a director of the Company since 2003. At the time of his resignation, Mr. Baron served on the Audit Committee and Compensation Committee and as Chair of the Corporate Governance and Nominating Committee of the Board.

Mr. Baron’s resignation is not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

Dmitry Kolosov, an existing member of the Board, was appointed to the Audit Committee as a third independent director to temporarily fill the vacancy created by Mr. Baron’s resignation.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.